[19 February 2014]
Products Affected - Description
Thiothixene capsules, Mylan Institutional
2 mg capsules, 100 count, unit dose (NDC 51079-0587-20)
5 mg capsules, 100 count, unit dose (NDC 51079-0588-20)
10 mg capsules, 100 count, unit dose (NDC 51079-0589-20)
Reason for the Shortage
- Pfizer discontinued Navane (thiothixene) 2 mg, 10 mg, and 20 mg presentations in the fall of 2011. The Navane 5 mg presentation was discontinued previously.
- Sandoz discontinued all thiothixene presentations in early-2012.
- Mylan discontinued thiothixene 10 mg capsules in 1000 count in the first half of 2011 and discontinued thiothixene 2 mg and 5 mg capsules in 1000 count in early-April, 2012.
- Mylan cannot provide a reason for the shortage.
Thiothixene capsules, Mylan
1 mg capsules, 100 count (NDC 00378-1001-01)
2 mg capsules, 100 count (NDC 00378-2002-01)
5 mg capsules, 100 count (NDC 00378-3005-01)
10 mg capsules, 100 count (NDC 00378-5010-01)
Estimated Resupply Dates
Mylan Institutional has thiothixene 2 mg, 5 mg, and 10 mg capsules in 100 count unit dose on back order and the company cannot estimate a release date.
February 19, 2014; January 24, 2014; December 12, 2013, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins